A scRNAseq analysis of peripheral circulating T cells from patients with tumors treated with ICIs revealed a significant increase in the abundance of CD4+ TH17 cells in those who developed ICI-induced thyroiditis compared to control patients (70). Here, CD4 is linked to thyroiditis.